Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
Johnson and Johnson

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,773,696

« Back to Dashboard

Summary for Patent: 6,773,696

Title: Contrast agent comprising low density microspheres
Abstract:Low density microspheres, methods for preparing same, and use of same as contrast agents are described. The microspheres have a void having a volume that comprises at least about 75% of the total volume of the microspheres, and which contains a gas or the vapor of a volatile liquid selected from the group consisting of aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes and perfluorocarbons.
Inventor(s): Unger; Evan C. (Tucson, AZ)
Assignee: Bristol-Myers Squibb Medical Imaging, Inc. (Princeton, NJ)
Application Number:10/280,844
Patent Claim Types:
see list of patent claims
Compound; Delivery;

No matches for this query

International Patent Family for Patent: 6,773,696

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2191079► Subscribe
China1149259► Subscribe
China1160357► Subscribe
Germany69229342► Subscribe
Germany69231830► Subscribe
Denmark0580726► Subscribe
Denmark0804932► Subscribe
European Patent Office0580726► Subscribe
European Patent Office0760684► Subscribe
European Patent Office0762899► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus